Literature DB >> 3608127

Frequency-dependent effects of amiodarone on atrioventricular nodal function and slow-channel action potentials: evidence for calcium channel-blocking activity.

S Nattel, M Talajic, M Quantz, M DeRoode.   

Abstract

The purpose of these experiments was to determine the frequency dependence of the effects of amiodarone and its active desethyl metabolite on slow-channel tissues. Intravenous amiodarone and desethylamiodarone (10 or 25 mg/kg) increased atrioventricular conduction time (AVCT) and refractory period (AVERP) in open-chest, chloralose-anesthetized dogs. Drug effects on AVCT and AVERP were greatly augmented by increasing atrial stimulation frequency. The frequency dependence of drug effects was quantified by studying the response of atrioventricular (AV) conduction to changes in coupling interval. Under control conditions, premature atrial stimulation increased AVCT with a time constant of 70 msec. In the presence of amiodarone and desethylamiodarone, a biexponential relationship between AVCT and coupling interval was observed. One component had a time constant similar to control, and a slower component with a time constant of about 1 sec appeared. Slow-channel action potentials produced in canine cardiac false tendons by elevated potassium (25 mM) and isoproterenol in vitro showed interval-dependent changes in Vmax with a time constant averaging 74 msec in the absence of amiodarone. In the presence of amiodarone, a slower recovery phase of Vmax with a time constant averaging 0.94 sec was observed. These results indicate that amiodarone and its metabolite produce heart rate-dependent changes in AV nodal function in vivo and suggest use-dependent calcium-channel blockade as a mechanism of this action. Amiodarone's rate-related effects on slow-channel properties should produce selective depression of supraventricular tachyarrhythmias involving rapid activation of the AV node.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3608127     DOI: 10.1161/01.cir.76.2.442

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  15 in total

Review 1.  Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.

Authors:  S Nattel
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

Review 2.  Drug effects on the electrocardiogram. A review of their clinical importance.

Authors:  J D Symanski; L S Gettes
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

3.  Comparison of the chronic and acute effects of amiodarone on the calcium and potassium currents in rabbit isolated cardiac myocytes.

Authors:  A Varró; L Virág; J G Papp
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 4.  Recent advances in understanding the pharmacology of amiodarone.

Authors:  S Nattel; M Talajic
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

5.  Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia.

Authors:  Yalda Jamshidi; Ilja M Nolte; Chrysoula Dalageorgou; Dongling Zheng; Toby Johnson; Rachel Bastiaenen; Suzanne Ruddy; Daniel Talbott; Kris J Norris; Harold Snieder; Alfred L George; Vanessa Marshall; Saad Shakir; Prince J Kannankeril; Patricia B Munroe; A John Camm; Steve Jeffery; Dan M Roden; Elijah R Behr
Journal:  J Am Coll Cardiol       Date:  2012-06-06       Impact factor: 24.094

6.  Comparison of acute electrophysiological effects of amiodarone and its metabolite desethylamiodarone in Langendorff perfused guinea pig hearts.

Authors:  G Stark; U Stark; M Windisch; M Vicenzi; U Eggenreich; S Nagl; K Kral; E Pilger; H A Tritthart
Journal:  Basic Res Cardiol       Date:  1991 Mar-Apr       Impact factor: 17.165

Review 7.  Amiodarone in long term prophylaxis.

Authors:  D Katritsis; A J Camm
Journal:  Drugs       Date:  1991       Impact factor: 9.546

8.  Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial.

Authors:  J Butler; D R Harriss; M Sinclair; S Westaby
Journal:  Br Heart J       Date:  1993-07

Review 9.  Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

Authors:  J Gill; R C Heel; A Fitton
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

10.  Class III antiarrhythmic drugs (amiodarone, bretylium and sotalol) on action potentials and membrane currents in rabbit sino-atrial node preparations.

Authors:  H Satoh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.